Intraoperative Red Blood Cell Transfusion and Primary Graft Dysfunction After Lung Transplantation.
Journal
Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144
Informations de publication
Date de publication:
01 07 2023
01 07 2023
Historique:
medline:
23
6
2023
pubmed:
25
3
2023
entrez:
24
3
2023
Statut:
ppublish
Résumé
In this international, multicenter study of patients undergoing lung transplantation (LT), we explored the association between the amount of intraoperative packed red blood cell (PRBC) transfusion and occurrence of primary graft dysfunction (PGD) and associated outcomes. The Extracorporeal Life Support in LT Registry includes data on LT recipients from 9 high-volume (>40 transplants/y) transplant centers (2 from Europe, 7 from the United States). Adult patients who underwent bilateral orthotopic lung transplant from January 2016 to January 2020 were included. The primary outcome of interest was the occurrence of grade 3 PGD in the first 72 h after LT. We included 729 patients who underwent bilateral orthotopic lung transplant between January 2016 and November 2020. LT recipient population tertiles based on the amount of intraoperative PRBC transfusion (0, 1-4, and >4 units) were significantly different in terms of diagnosis, age, gender, body mass index, mean pulmonary artery pressure, lung allocation score, hemoglobin, prior chest surgery, preoperative hospitalization, and extracorporeal membrane oxygenation requirement. Inverse probability treatment weighting logistic regression showed that intraoperative PRBC transfusion of >4 units was significantly ( P < 0.001) associated with grade 3 PGD within 72 h (odds ratio [95% confidence interval], 2.2 [1.6-3.1]). Inverse probability treatment weighting analysis excluding patients with extracorporeal membrane oxygenation support produced similar findings (odds ratio [95% confidence interval], 2.4 [1.7-3.4], P < 0.001). In this multicenter, international registry study of LT patients, intraoperative transfusion of >4 units of PRBCs was associated with an increased risk of grade 3 PGD within 72 h. Efforts to improve post-LT outcomes should include perioperative blood conservation measures.
Sections du résumé
BACKGROUND
In this international, multicenter study of patients undergoing lung transplantation (LT), we explored the association between the amount of intraoperative packed red blood cell (PRBC) transfusion and occurrence of primary graft dysfunction (PGD) and associated outcomes.
METHODS
The Extracorporeal Life Support in LT Registry includes data on LT recipients from 9 high-volume (>40 transplants/y) transplant centers (2 from Europe, 7 from the United States). Adult patients who underwent bilateral orthotopic lung transplant from January 2016 to January 2020 were included. The primary outcome of interest was the occurrence of grade 3 PGD in the first 72 h after LT.
RESULTS
We included 729 patients who underwent bilateral orthotopic lung transplant between January 2016 and November 2020. LT recipient population tertiles based on the amount of intraoperative PRBC transfusion (0, 1-4, and >4 units) were significantly different in terms of diagnosis, age, gender, body mass index, mean pulmonary artery pressure, lung allocation score, hemoglobin, prior chest surgery, preoperative hospitalization, and extracorporeal membrane oxygenation requirement. Inverse probability treatment weighting logistic regression showed that intraoperative PRBC transfusion of >4 units was significantly ( P < 0.001) associated with grade 3 PGD within 72 h (odds ratio [95% confidence interval], 2.2 [1.6-3.1]). Inverse probability treatment weighting analysis excluding patients with extracorporeal membrane oxygenation support produced similar findings (odds ratio [95% confidence interval], 2.4 [1.7-3.4], P < 0.001).
CONCLUSIONS
In this multicenter, international registry study of LT patients, intraoperative transfusion of >4 units of PRBCs was associated with an increased risk of grade 3 PGD within 72 h. Efforts to improve post-LT outcomes should include perioperative blood conservation measures.
Identifiants
pubmed: 36959119
doi: 10.1097/TP.0000000000004545
pii: 00007890-202307000-00023
doi:
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1573-1579Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult lung and heart-lung transplant report—2011. J Heart Lung Transplant. 2011;30:1104–1122.
Christie JD, Edwards LB, Kucheryavaya AY, et al.; International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report—2012. J Heart Lung Transplant. 2012;31:1073–1086.
Yusen RD, Christie JD, Edwards LB, et al.; International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report—2013; focus theme: age. J Heart Lung Transplant. 2013;32:965–978.
Liu Y, Liu Y, Su L, et al. Recipient-related clinical risk factors for primary graft dysfunction after lung transplantation: a systematic review and meta-analysis. PLoS One. 2014;9:e92773.
Diamond JM, Lee JC, Kawut SM, et al.; Lung Transplant Outcomes Group. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2013;187:527–534.
Fang A, Studer S, Kawut SM, et al.; Lung Transplant Outcomes Group. Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis. Chest. 2011;139:782–787.
Snell GI, Yusen RD, Weill D, et al. Report of the ISHLT working group on primary lung graft dysfunction, part I: definition and grading—a 2016 Consensus Group Statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2017;36:1097–1103.
Cantu E, Diamond JM, Suzuki Y, et al.; Lung Transplant Outcomes Group. Quantitative evidence for revising the definition of primary graft dysfunction after lung transplant. Am J Respir Crit Care Med. 2018;197:235–243.
Prekker ME, Nath DS, Walker AR, et al. Validation of the proposed international society for heart and lung transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant. 2006;25:371–378.
Whitson BA, Prekker ME, Herrington CS, et al. Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant. 2007;26:1004–1011.
Lee JC, Christie JD. Primary graft dysfunction. Proc Am Thorac Soc. 2009;6:39–46.
Ong LP, Thompson E, Sachdeva A, et al. Allogeneic blood transfusion in bilateral lung transplantation: impact on early function and mortality. Eur J Cardiothorac Surg. 2016;49:668–674.
Loor G, Koch CG, Sabik JF, et al. Implications and management of anemia in cardiac surgery: current state of knowledge. J Thorac Cardio Surg. 2012;144:538–546.
Loor G, Rajeswaran J, Li L, et al. The least of 3 evils: exposure to red blood cell transfusion, anemia, or both? J Thorac Cardio Surg. 2013;146:1480–1487.e1486.
Subramaniam K, Gabriel L, Bottiger B, et al. Intraoperative red blood cell transfusion is associated with primary graft dysfunction after lung transplantation. Am J Resp Crit Care Med. 2021;203:A1785.
Hartwig M, Loor G, Bottiger B, et al. Effect of time of intraoperative circulatory support on incidence of high-grade primary graft dysfunction (PGD): multicenter analysis on use of extracorporeal life support (ECLS) during lung transplantation. J Heart Lung Transplant. 2020;39:S328–S329.
Burton CM, Iversen M, Milman N, et al. Outcome of lung transplanted patients with primary graft dysfunction. Eur J Cardiothorac Surg. 2007;31:75–82.
Bermudez CA, Adusumilli PS, McCurry KR, et al. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: long-term survival. Ann Thorac Surg. 2009;87:854–860.
Kim HJ, Cha SI, Kim CH, et al. Risk factors of postoperative acute lung injury following lobectomy for nonsmall cell lung cancer. Medicine (Baltimore). 2019;98:e15078.
Vlaar AP, Hofstra JJ, Determann RM, et al. Transfusion-related acute lung injury in cardiac surgery patients is characterized by pulmonary inflammation and coagulopathy: a prospective nested case-control study. Crit Care Med. 2012;40:2813–2820.
Hod EA, Zhang N, Sokol SA, et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood. 2010;115:4284–4292.
Miki C, Hiro J, Ojima E, et al. Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol (R Coll Radiol). 2006;18:60–66.
Hensler T, Heinemann B, Sauerland S, et al. Immunologic alterations associated with high blood transfusion volume after multiple injury: effects on plasmatic cytokine and cytokine receptor concentrations. Shock. 2003;20:497–502.
Stark MJ, Keir AK, Andersen CC. Does non-transferrin bound iron contribute to transfusion related immune-modulation in preterms? Arch Dis Child Fetal Neonatal Ed. 2013;98:F424–F429.
De Perrot M, Sekine Y, Fischer S, et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med. 2002;165:211–215.
Hoffman SA, Wang L, Shah CV, et al.; Lung Transplant Outcomes Group. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant. 2009;9:389–396.
Moreno I, Vicente R, Ramos F, et al. Determination of interleukin-6 in lung transplantation: association with primary graft dysfunction. Transplant Proc. 2007;39:2425–2426.
Porteous MK, Lee JC, Lederer DJ, et al.; Lung Transplant Outcomes Group. Clinical risk factors and prognostic model for primary graft dysfunction after lung transplantation in patients with pulmonary hypertension. Ann Am Thorac Soc. 2017;14:1514–1522.
Cernak V, Oude Lansink-Hartgring A, van den Heuvel ER, et al. Incidence of massive transfusion and overall transfusion requirements during lung transplantation over a 25-year period. J Cardiothorac Vasc Anesth. 2019;33:2478–2486.
Smith I, Pearse BL, Faulke DJ, et al. Targeted bleeding management reduces the requirements for blood component therapy in lung transplant recipients. J Cardiothorac Vasc Anesth. 2017;31:426–433.
Cottini SR, Brandi G, Pagnamenta A, et al. Pulmonary hypertension is not a risk factor for grade 3 primary graft dysfunction after lung transplantation. Clin Transplant. 2018;32:e13251.
Hernandez-Morgan M, Neelankavil J, Grogan T, et al. Preoperative anemia as a risk factor for postoperative outcomes in patients undergoing lung transplantation. J Cardiothorac Vasc Anesth. 2021;35:2311–2318.
Durila M, Vajter J, Garaj M, et al. Rotational thromboelastometry reduces blood loss and blood product usage after lung transplantation. J Heart Lung Transplant. 2021;40:631–641.
Barac YD, Klapper J, Pollack A, et al. Anticoagulation strategies in the perioperative period for lung transplant. Ann Thorac Surg. 2020;110:e23–e25.
Bhaskar B, Zeigenfuss M, Choudhary J, et al. Use of recombinant activated factor vii for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications. Transfusion. 2013;53:798–804.
Huddleston SJ, Jackson S, Kane K, et al. Separate effect of perioperative recombinant human factor VIIa administration and packed red blood cell transfusions on midterm survival in lung transplantation recipients. J Cardiothorac Vasc Anesth. 2020;34:3013–3020.
Chan EG, Hyzny EJ, Furukawa M, et al. Intraoperative support for primary bilateral lung transplantation: a propensity-matched analysis. Ann Thorac Surg. 2023;115:743–749.
Magouliotis DE, Tasiopoulou VS, Svokos AA, et al. Extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation: a meta-analysis. Gen Thorac Cardiovasc Surg. 2018;66:38–47.
Weber D, Cottini SR, Locher P, et al. Association of intraoperative transfusion of blood products with mortality in lung transplant recipients. Perioper Med (Lond). 2013;2:20.
Karrowni W, Vora AN, Dai D, et al. Blood transfusion and the risk of acute kidney injury among patients with acute coronary syndrome undergoing percutaneous coronary intervention. Circ Cardiovasc Interv. 2016;9:e003279.
Li CN, Ge YP, Liu H, et al. Blood transfusion and acute kidney injury after total aortic arch replacement for acute Stanford type A aortic dissection. Heart Lung Circ. 2022;31:136–143.
Nuis R-J, Rodés-Cabau J, Sinning J-M, et al. Blood transfusion and the risk of acute kidney injury after transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2012;5:680–688.
Rasmussen SR, Kandler K, Nielsen RV, et al. Association between transfusion of blood products and acute kidney injury following cardiac surgery. Acta Anaesthesiol Scand. 2020;64:1397–1404.
Knight J, Hill A, Melnyk V, et al. Intraoperative hypoxia independently associated with the development of acute kidney injury following bilateral orthotopic lung transplantation. Transplantation. 2022;106:879–886.
Seay T, Guinn N, Maisonave Y, et al. The association of increased FFP:RBC transfusion ratio to primary graft dysfunction in bleeding lung transplantation patients. J Cardiothorac Vasc Anesth. 2020;34:3024–3032.
Ong LP, Sachdeva A, Ramesh BC, et al. Lung transplant with cardiopulmonary bypass: impact of blood transfusion on rejection, function, and late mortality. Ann Thorac Surg. 2016;101:512–519.
Zalunardo MP, Thalmann C, Seifert B, et al. Impact of preoperative right-ventricular function and platelet transfusion on outcome after lung transplantation. Eur J Cardiothorac Surg. 2011;39:538–542.